reference/25418434

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/25418434

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, P.H.S.
endingPage	9
issn	0008-5472
issueIdentifier	15
pageRange	4481-9
publicationName	Cancer research
startingPage	4481
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_95764603428fda2d8a23f99eab41e746 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_594f5fc7f5092094e2d7671eda2f7adc
bibliographicCitation	Tatsumi T, Herrem CJ, Olson WC, Finke JH, Bukowski RM, Kinch MS, Ranieri E, Storkus WJ. Disease stage variation in CD4+ and CD8+ T-cell reactivity to the receptor tyrosine kinase EphA2 in patients with renal cell carcinoma. Cancer Res. 2003 Aug 01;63(15):4481–9. PMID: 12907621.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cebef28f66d936ad2d903d54ac5b9920 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1293523d1b196eb34ee5da999bcd2688 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_96dd48875e9c104ce9bc3c021d41ceec http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bbb94a57ac21ede7d1acd1691703dcdb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7ac952db92449047efcc96abca61bb44 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_720d096746fb4427ab4d7d13dacced19 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6785cd4ebf76eff307d080e51d930898 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d02af303960d5da1e9cb11956810a948
date	2003-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/12907621
isPartOf	https://portal.issn.org/resource/ISSN/0008-5472 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2786
language	English
source	https://pubmed.ncbi.nlm.nih.gov/
title	Disease stage variation in CD4+ and CD8+ T-cell reactivity to the receptor tyrosine kinase EphA2 in patients with renal cell carcinoma
discusses	http://id.nlm.nih.gov/mesh/M0180256 http://id.nlm.nih.gov/mesh/M0024267 http://id.nlm.nih.gov/mesh/M0011490 http://id.nlm.nih.gov/mesh/M0028355 http://id.nlm.nih.gov/mesh/M0024757 http://id.nlm.nih.gov/mesh/M0025510
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D002292Q000276 http://id.nlm.nih.gov/mesh/D007680Q000276 http://id.nlm.nih.gov/mesh/D036104Q000276 http://id.nlm.nih.gov/mesh/D018414Q000276 http://id.nlm.nih.gov/mesh/D015496Q000276
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D007371Q000378 http://id.nlm.nih.gov/mesh/D018414Q000378 http://id.nlm.nih.gov/mesh/D002292Q000378 http://id.nlm.nih.gov/mesh/D002292Q000473 http://id.nlm.nih.gov/mesh/D000595 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D036104Q000096 http://id.nlm.nih.gov/mesh/D016212Q000097 http://id.nlm.nih.gov/mesh/D007680Q000473 http://id.nlm.nih.gov/mesh/D016212Q000096 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D015496Q000378 http://id.nlm.nih.gov/mesh/D009367 http://id.nlm.nih.gov/mesh/D018984Q000276 http://id.nlm.nih.gov/mesh/D007680Q000378 http://id.nlm.nih.gov/mesh/D008213Q000276 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D018604 http://id.nlm.nih.gov/mesh/D015848Q000097 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D016753Q000096 http://id.nlm.nih.gov/mesh/D016753Q000097 http://id.nlm.nih.gov/mesh/D015848Q000378 http://id.nlm.nih.gov/mesh/D008969 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D007371Q000097 http://id.nlm.nih.gov/mesh/D000328
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7170 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_68000b5f90a1d5b5b1a93dbb8aa92d3e http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4b314c92a79e626165622f7b6869f840 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_29f84c0d894769b14b36c5f43f54153e

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459

Total number of triples: 71.